Skip to main content
Clinical Trials/JPRN-jRCT1080220348
JPRN-jRCT1080220348
Unknown
Phase 4

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Long-Term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease as Measured by Intravascular Ultrasonography

AstraZeneca/Shionogi0 sitesJanuary 31, 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hypercholesteremia
Sponsor
AstraZeneca/Shionogi
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2007
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
AstraZeneca/Shionogi

Eligibility Criteria

Inclusion Criteria

  • Ages Eligible for Study: 20 Years \- 75 Years
  • Genders Eligible for Study: Both
  • Inclusion Criteria:
  • \- Signed written informed consent,
  • \- 20 to 75 years old,
  • \- Plan to undergo coronary angiography (CAG) or PCI and LDL\-C \= 140 mg/dL (untreated patients) or LDL\-C \=100 mg/dL (treated patients

Exclusion Criteria

  • \- Acute myocardial infarction within 72 hours after the onset,
  • \- Heart failure of NYHA Class III or above,
  • \- Serious arrhythmia,
  • \- Being treated with LDL\-apheresis
  • \- History of serious reaction or hypersensitivity to other HMG\-CoA reductase inhibitors.

Outcomes

Primary Outcomes

Not specified

Similar Trials